AI shows promise for predicting embryonic health without invasive testing

Researchers evaluate the effectiveness of artificial intelligence algorithms in non-invasively predicting embryonic ploidy from embryonic images.

Charging patients to message their doctors mostly benefits major hospital systems

Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for

March 6, 2024

Many patients with Lynch syndrome remain undiagnosed, study finds

New research from Cedars-Sinai Cancer investigators could warrant reconsideration of current screening guidelines to include a poorly recognized cause of Lynch syndrome, the most common

July 12, 2023

Clinigen clears out cancer therapies in line with latest growth strategy – Pharmaceutical Technology

This action follows Clinigen’s January 2023 sale of its kidney cancer treatment Proleukin (aldesleukin) to Iovance Biotherapeutics. Credit: Volodymyr Maksymchuk via Shutterstock. UK-headquartered Clinigen announced

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.